1. Home
  2. AOMR vs ANIK Comparison

AOMR vs ANIK Comparison

Compare AOMR & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AOMR

Angel Oak Mortgage REIT Inc.

N/A

Current Price

$8.28

Market Cap

210.5M

Sector

Real Estate

ML Signal

N/A

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

N/A

Current Price

$21.53

Market Cap

200.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AOMR
ANIK
Founded
2018
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
210.5M
200.9M
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
AOMR
ANIK
Price
$8.28
$21.53
Analyst Decision
Strong Buy
Buy
Analyst Count
3
1
Target Price
$11.08
$17.00
AVG Volume (30 Days)
137.0K
111.2K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
14.18%
N/A
EPS Growth
53.85
80.16
EPS
N/A
N/A
Revenue
N/A
$112,819,000.00
Revenue This Year
N/A
$5.98
Revenue Next Year
$1.38
$7.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.96
$8.56
52 Week High
$10.14
$22.88

Technical Indicators

Market Signals
Indicator
AOMR
ANIK
Relative Strength Index (RSI) 41.96 58.58
Support Level $8.09 $14.00
Resistance Level $8.53 $22.70
Average True Range (ATR) 0.19 0.89
MACD -0.03 -0.23
Stochastic Oscillator 23.75 48.85

Price Performance

Historical Comparison
AOMR
ANIK

About AOMR Angel Oak Mortgage REIT Inc.

Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in first and second lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation, across interest rate and credit cycles. The company operates in a single operating segment, which is to acquire, invest in, and finance mortgage-related assets.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: